Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease.
暂无分享,去创建一个
M. Grisham | R. Wolf | K. Pavlick | F. S. Laroux | J. Fuseler | L. Gray | J. Hoffman | F Stephen Laroux | Matthew B Grisham | Kevin P Pavlick | John Fuseler | Robert E Wolf | Laura Gray | Jason Hoffman | F. Laroux
[1] M. Grisham,et al. Effects of neutrophil-derived oxidants on intestinal permeability, electrolyte transport, and epithelial cell viability , 1990, Inflammation.
[2] C. Obinger,et al. Reaction of myeloperoxidase compound I with chloride, bromide, iodide, and thiocyanate. , 1998, Biochemistry.
[3] M. Miller,et al. Amelioration of chronic ileitis by nitric oxide synthase inhibition. , 1993, The Journal of pharmacology and experimental therapeutics.
[4] D. Granger,et al. Regulation of Murine Intestinal Inflammation by Reactive Metabolites of Oxygen and Nitrogen , 2001, The Journal of experimental medicine.
[5] S. Abramson,et al. The role of nitric oxide in inflammation and immunity. , 1998, Arthritis and rheumatism.
[6] G. Rogler,et al. Subtractive screening reveals up‐regulation of NADPH oxidase expression in Crohn's disease intestinal macrophages , 2001, Clinical and experimental immunology.
[7] P. Libby,et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.
[8] M. Currie,et al. The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey. , 1997, The Journal of pharmacology and experimental therapeutics.
[9] M. Mollet,et al. Phase II trial of copper zinc superoxide dismutase (CuZnSOD) in treatment of Crohn's disease. , 1989, Free radical biology & medicine.
[10] J. Doroshow,et al. Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[11] K. Matsumoto,et al. Oxygen-derived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis. , 1989, Digestion.
[12] E. Chang,et al. Effect of the thiol-oxidizing agent diamide on NH2Cl-induced rat colonic electrolyte secretion. , 1993, The American journal of physiology.
[13] R. Cashon,et al. Redox reactions of hemoglobin and myoglobin: biological and toxicological implications. , 2001, Antioxidants & redox signaling.
[14] R. Schmid,et al. Inhibition of nitric oxide synthesis by aminoguanidine increases intestinal damage in the acute phase of rat TNB‐colitis , 2001, European journal of clinical investigation.
[15] H. Verspaget,et al. Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease. , 1991, Gut.
[16] John I. Gallin,et al. Inflammation: Basic Principles and Clinical Correlates , 1992 .
[17] P. Kubes,et al. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. , 1997, Gastroenterology.
[18] Dean P. Jones,et al. Exogenous glutathione protects intestinal epithelial cells from oxidative injury. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[19] C. Schorah. Antioxidants in children with inflammatory bowel disease. , 1998, American Journal of Clinical Nutrition.
[20] J. Davis,et al. Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis. , 1997, The Journal of pharmacology and experimental therapeutics.
[21] H. Lander. An essential role for free radicals and derived species in signal transduction , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] D. Harrison,et al. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[23] L. Coussens,et al. Inflammation and cancer , 2002, Nature.
[24] M. Grisham,et al. Preparation and characterization of chloramines. , 1986, Methods in enzymology.
[25] S. Weiss,et al. Proteolytic inactivation of alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases. , 1992, The Journal of biological chemistry.
[26] N. Oshitani,et al. Location of superoxide anion generation in human colonic mucosa obtained by biopsy. , 1993, Gut.
[27] H. Nick,et al. Induction and immunolocalization of manganese superoxide dismutase in acute acetic acid-induced colitis in the rat. , 1995, Gastroenterology.
[28] S. Pizzo,et al. Oxidative dissociation of human alpha 2-macroglobulin tetramers into dysfunctional dimers. , 1994, The Journal of biological chemistry.
[29] M. Grisham,et al. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. , 1994, The Journal of pharmacology and experimental therapeutics.
[30] J. Weidner,et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. , 1996, Gastroenterology.
[31] Barry Halliwell,et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils , 1998, Nature.
[32] C. Elson,et al. Experimental models of inflammatory bowel disease. , 1995, Gastroenterology.
[33] H. Goto,et al. Role Of Nitric Oxide Synthase Inhibitor In Experimental Colitis Induced By 2,4,6‐Trinitrobenzene Sulphonic Acid In Rats , 2001, Clinical and experimental pharmacology & physiology.
[34] C. Pasquier,et al. Phase II trial of copper zinc superoxide dismutase (CuZn SOD) in the treatment of Crohn's disease. , 1991, Free radical research communications.
[35] A. Keshavarzian,et al. Reactive oxygen and nitrogen metabolites as mediators of secretory diarrhea. , 1995, Gastroenterology.
[36] E. Chang,et al. Ca-mediated stimulation of Cl secretion by reactive oxygen metabolites in human colonic T84 cells. , 1992, The Journal of clinical investigation.
[37] D. Lefer,et al. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. , 1998, Free radical biology & medicine.
[38] F. Powrie,et al. T cells in inflammatory bowel disease: protective and pathogenic roles. , 1995, Immunity.
[39] M. Grisham. Oxidants and free radicals in inflammatory bowel disease , 1994, The Lancet.
[40] W. Doe,et al. 5-Aminosalicylic acid prevents oxidant mediated damage of glyceraldehyde-3-phosphate dehydrogenase in colon epithelial cells , 1999, Gut.
[41] C. Herfarth,et al. Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease , 1998, Gut.
[42] M. Russel,et al. Nutritional Supplementation with N‐3 Fatty Acids and Antioxidants in Patients with Crohn's Disease in Remission: Effects on Antioxidant Status and Fatty Acid Profile , 2000, Inflammatory bowel diseases.
[43] F. Powrie,et al. Regulatory T cells and inflammatory bowel disease. , 1999, Immunology today.
[44] T. Aw. Molecular and cellular responses to oxidative stress and changes in oxidation-reduction imbalance in the intestine. , 1999, The American journal of clinical nutrition.
[45] D. Wink,et al. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[46] R. Macdermott,et al. Oxidant defense mechanisms in the human colon , 1990, Inflammation.
[47] Hervé Groux,et al. A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.
[48] A. Keshavarzian,et al. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. , 1992, Gastroenterology.
[49] O. Nielsen,et al. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. , 1990, Gastroenterology.
[50] D. Roos,et al. Interactions between the components of the human NADPH oxidase: a review about the intrigues in the phox family. , 1996, Frontiers in bioscience : a journal and virtual library.
[51] M. Grisham. Effect of 5-aminosalicylic acid on ferrous sulfate-mediated damage to deoxyribose. , 1990, Biochemical pharmacology.
[52] Richard Graham Knowles,et al. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine. , 2001, The Journal of pharmacology and experimental therapeutics.
[53] F. Powrie,et al. CD4(+) regulatory T cells. , 2001, Current opinion in immunology.
[54] J. Davis,et al. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: toxins, mediators, and modulators of gene expression. , 1996, Inflammatory bowel diseases.
[55] S. Weiss. Tissue destruction by neutrophils. , 1989, The New England journal of medicine.
[56] P. Bass,et al. Differences in the reducing power along the rat GI tract: Lower antioxidant capacity of the colon , 1999, Molecular and Cellular Biochemistry.
[57] F. Powrie,et al. Control of intestinal inflammation by regulatory T cells , 2001, Immunological reviews.
[58] D. Learn,et al. Mutagenic activity of chloramines. , 1987, Mutation research.
[59] M. Yüksel,et al. The effect of antioxidant therapy on colonic inflammation in the rat , 1999, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.
[60] M. Grisham,et al. Effects of nitric oxide synthase inhibition or sulfasalazine on the spontaneous colitis observed in HLA-B27 transgenic rats. , 1998, The Journal of pharmacology and experimental therapeutics.
[61] J. Jackson,et al. Mechanisms of hypochlorite injury of target cells. , 1990, The Journal of clinical investigation.
[62] M. Grisham,et al. Effects of aminosalicylates and immunosuppressive agents on nitric oxide-dependent N-nitrosation reactions. , 1994, Biochemical pharmacology.
[63] S. Weitzman,et al. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. , 1990, Blood.
[64] David Baltimore,et al. NF-κB: Ten Years After , 1996, Cell.
[65] D. Rampton,et al. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. , 1992, Gastroenterology.
[66] M. Baker,et al. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. , 1996, The Journal of clinical investigation.
[67] L. Dubé,et al. A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group For Ulcerative Colitis. , 1997, Gastroenterology.
[68] S. Hazen,et al. Eosinophil Peroxidase Oxidation of Thiocyanate , 2001, The Journal of Biological Chemistry.
[69] C. Fiocchi. Inflammatory bowel disease: etiology and pathogenesis. , 1998, Gastroenterology.
[70] N. Nieto,et al. Experimental Ulcerative Colitis Impairs Antioxidant Defense System in Rat Intestine , 2000, Digestive Diseases and Sciences.
[71] P. Reilly,et al. Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenon? , 1992, Pharmacology & therapeutics.
[72] D. Learn,et al. Myeloperoxidase-catalyzed chlorination of histamine by stimulated neutrophils , 2000, Redox report : communications in free radical research.
[73] M. Neurath,et al. Local administration of antisense phosphorothiate olignucleotides to the p65 subunit of NF–κB abrogates established experimental colitis in mice , 1996, Nature Medicine.
[74] Y. Zhou,et al. Role of copper zinc superoxide dismutase in the short-term treatment of acetic acid-induced colitis in rats. , 1996, Acta gastroenterologica Latinoamericana.
[75] M. John,et al. Enhanced Expression of iNOS in Inflamed Colons of IL‐2‐Deficient Mice Does Not Impair Colonic Epithelial Barrier Function , 2000, Annals of the New York Academy of Sciences.
[76] A. Keshavarzian,et al. Glutathione Content of Colonic Mucosa (Evidence for Oxidative Damage in Active Ulcerative Colitis) , 1998, Digestive Diseases and Sciences.
[77] P. Libby,et al. Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB (*) , 1995, The Journal of Biological Chemistry.
[78] W. Doe,et al. Depleted mucosal antioxidant defences in inflammatory bowel disease. , 1995, Free radical biology & medicine.
[79] R. Haggitt,et al. Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591. , 1997, Gastroenterology.
[80] S. Hazen,et al. Eosinophil peroxidase catalyzes bromination of free nucleosides and double-stranded DNA. , 2001, Biochemistry.
[81] M. Grisham,et al. Antioxidant properties of aminosalicylates. , 1994, Methods in enzymology.
[82] Tamaki Yamada,et al. The effects of sulfasalazine metabolites on hemoglobin-catalyzed lipid peroxidation. , 1991, Free radical biology & medicine.
[83] P. Cerutti,et al. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B. , 1995, Chemistry & biology.
[84] G. Garcı́a-Cardeña,et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. , 1997, The Journal of clinical investigation.
[85] T. Aw,et al. Biliary glutathione promotes the mucosal metabolism of luminal peroxidized lipids by rat small intestine in vivo. , 1994, The Journal of clinical investigation.
[86] J. Stamler,et al. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. , 1995, Gut.
[87] D. Rachmilewitz,et al. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. , 1995, Gut.
[88] J S Beckman,et al. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.
[89] M. Grisham,et al. Effect of nitric oxide on hemoprotein-catalyzed oxidative reactions. , 1998, Nitric oxide : biology and chemistry.
[90] C. Hogaboam,et al. The selective beneficial effects of nitric oxide inhibition in experimental colitis. , 1995, The American journal of physiology.
[91] A. Blackburn,et al. Protein carbonyl formation on mucosal proteins in vitro and in dextran sulfate-induced colitis. , 1999, Free radical biology & medicine.
[92] S. Kawachi,et al. Role of inducible nitric oxide synthase in the regulation of VCAM-1 expression in gut inflammation. , 1999, American journal of physiology. Gastrointestinal and liver physiology.